ID: ALA4447931

Max Phase: Preclinical

Molecular Formula: C25H38N2O3

Molecular Weight: 414.59

Molecule Type: Unknown

Representations

Canonical SMILES:  Cc1ccc(C(=O)/C=C/C(=O)N(CC(C)C)C(C(=O)NC(C)(C)C)C(C)(C)C)cc1

Standard InChI:  InChI=1S/C25H38N2O3/c1-17(2)16-27(22(24(4,5)6)23(30)26-25(7,8)9)21(29)15-14-20(28)19-12-10-18(3)11-13-19/h10-15,17,22H,16H2,1-9H3,(H,26,30)/b15-14+

Standard InChI Key:  TXHGAEJPLOFESS-CCEZHUSRSA-N

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Unknown

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Properties

Molecular Weight: 414.59

Molecular Weight (Monoisotopic): 414.2882

AlogP: 4.55

#Rotatable Bonds: 7

Polar Surface Area: 66.48

Molecular Species: NEUTRAL

HBA: 3

HBD: 1

#RO5 Violations: 0

HBA (Lipinski): 5

HBD (Lipinski): 1

#RO5 Violations (Lipinski): 0

CX Acidic pKa:

CX Basic pKa:

CX LogP: 4.89

CX LogD: 4.89

Aromatic Rings: 1

Heavy Atoms: 30

QED Weighted: 0.53

Np Likeness Score: -0.74

References

1. Jovanović M, Zhukovsky D, Podolski-Renić A, Domračeva I, Žalubovskis R, Senćanski M, Glišić S, Sharoyko V, Tennikova T, Dar'in D, Pešić M, Krasavin M..  (2019)  Novel electrophilic amides amenable by the Ugi reaction perturb thioredoxin system via thioredoxin reductase 1 (TrxR1) inhibition: Identification of DVD-445 as a new lead compound for anticancer therapy.,  181  [PMID:31400708] [10.1016/j.ejmech.2019.111580]

Source

Source(1):

• Scientific Literature